![Ravi Mehrotra, MD Profile](https://pbs.twimg.com/profile_images/1388282055880970241/TzYHOf5f_x96.jpg)
Ravi Mehrotra, MD
@ravimehro
Followers
3K
Following
3K
Statuses
6K
Clinician-researcher dedicated to preventing cancer, with a focus on the impact of lifestyle choices like tobacco and alcohol consumption across countries.
🌎 India | United States
Joined February 2011
Escellent summary of evidence of the link between alcohol and cancer quoting experts @PublicGoodNews by @ValeRicciulli . I weigh in on the little known fact why women who drink have a much higher risk of certain alcohol-related problems than men. Please share for wider reach.
Alcohol is the third leading preventable cause of cancer in the United States, after tobacco and obesity—but few people know this. Learn more about the link between alcohol and cancer below 👇
0
4
5
@ValeRicciulli @HopkinsMedicine @VCU_Liver @juanpabloarab @EmoryUniversity Spanish version of the news article on Alcohol and cancer @ValeriaRicciulli for wider readership in @PublicGoodNews . @ValeriaRicciulli
0
1
2
RT @LovingVaccines: No symptoms do not mean no risk! #Cervicalcancer can stay hidden in its early stages. The Government of India recommend…
0
3
0
DYK: 'Nepal was earlier ranked at 4th position with regards to the size of pictorial health warnings globally back then. Nepal had laws to display 90% warnings on the front as well as the back packaging back then (now it is 100% on front and back both of all tobacco packaging). Timor-Leste had the largest pictorial warnings back then with 85% area on the front packaging displaying the warning and 100% on the back of the packaging with the warnings. Turkey also had the same size warnings as Timor-Leste. Maldives, Vanuatu, Benin had similar policies as of Nepal back then. Now, with 100% back and front packaging to display pictorial health warnings in Nepal, it is indeed a strongest possible implementation of lifesaving and proven tobacco control approach.'
0
0
1
The era of personalized cancer care is indeed transforming the landscape of oncology, encompassing not only screening but also therapy and survivorship. AI elaborates further: Personalized Cancer Screening Personalized screening involves tailoring screening protocols based on an individual's genetic makeup, family history, lifestyle, and other risk factors. This approach aims to detect cancer at its earliest stages when it is most treatable. For example, individuals with a family history of breast cancer may undergo more frequent mammograms or even genetic testing for BRCA mutations. Personalized Cancer Therapy Personalized therapy, also known as precision medicine, involves customizing treatment plans based on the genetic profile of both the patient and the tumor. This can include targeted therapies that specifically attack cancer cells with certain genetic mutations, as well as immunotherapies that harness the body's immune system to fight cancer. The goal is to maximize treatment efficacy while minimizing side effects. Personalized Survivorship Care Survivorship care is an essential component of the cancer care continuum, focusing on the health and well-being of individuals after cancer treatment. Personalized survivorship care plans are tailored to address the unique needs of each survivor, including: 1. Monitoring for Recurrence: Regular follow-ups and screenings based on the type of cancer and treatment received. 2. Managing Long-term Side Effects: Addressing physical and emotional changes resulting from cancer treatment, such as fatigue, pain, and anxiety. 3. Health Promotion: Encouraging healthy lifestyle choices, such as proper nutrition, exercise, and smoking cessation, to improve overall health and reduce the risk of recurrence. 4.Access to Personalized Cancer Care While the advancements in personalized cancer care are promising, access to these services remains a challenge for many. Factors such as socioeconomic status, geographic location, and healthcare infrastructure can limit access to personalized screening, therapy, and survivorship programs. Efforts are ongoing to bridge these gaps and ensure that more individuals can benefit from these advancements345. Conclusion The shift towards personalized cancer care represents a significant advancement in oncology, offering more effective and tailored approaches to cancer prevention, treatment, and survivorship. However, it is crucial to continue working towards making these services accessible to all, ensuring that everyone has the opportunity to benefit from the latest innovations in cancer care.
This year's #WorldCancerDay campaign places people at the centre of cancer care. A new Editorial in @TheLancetPH highlights the important role cancer screening can play in a people-centred approach to care:
0
0
4
RT @CACancerJournal: 🌍 Revisit @AmericanCancer @IARCWHO global cancer stats on #WorldCancerDay. ~20 million new cancer cases were diagnosed…
0
14
0
RT @TheLancet: The proportion of never-smokers diagnosed with lung cancer is on the rise, new global analysis suggests in @LancetRespirMed.…
0
67
0
@NiharikaDash14 Survivors should be celebrated and honoured for their courage and tremendous grit. Keep spreading the rays of hope and encouragement!
1
0
2
RT @TheLancet: Urgent action is needed to scale-up cancer prevention and care services. Cancer registries can play a crucial role in this.…
0
39
0
RT @projecthpvfree: A new study has found a 62% drop in deaths from cervical cancer among women under the age of 25 in the U.S. If you miss…
0
3
0
The WHO Cervical Cancer Initiative, also known as the Global Strategy to Accelerate the Elimination of Cervical Cancer, was launched by the World Health Organization. Here are some key points about the initiative: Goal: The initiative aims to eliminate cervical cancer as a public health problem. WHO has set a target to achieve this by the year 2030 with specific objectives: 90-70-90 Targets: 90% of girls fully vaccinated with the HPV vaccine by the age of 15. 70% of women screened using a high-performance test by the age of 35, and again by the age of 45. 90% of women identified with cervical disease receiving treatment (90% of women with pre-cancer treated and 90% of women with invasive cancer managed). Vaccination: Emphasis on increasing HPV vaccination coverage, particularly in low- and middle-income countries where access might be limited. Screening: Promoting high-quality screening programs that can detect precancerous lesions before they develop into cancer. Treatment: Ensuring that those diagnosed with cervical cancer or precancerous conditions have access to appropriate medical care, including treatment for both pre-cancerous lesions and invasive cancer. Equity and Access: A focus on reducing disparities in health care access globally, ensuring that services reach underserved populations. Awareness and Education: Increasing public awareness about cervical cancer, its prevention, and the importance of vaccination and screening. Research and Development: Supporting research for improved vaccines, screening methods, and treatments. Partnerships: Collaboration with governments, NGOs, research institutions, and the private sector to implement the strategy effectively. The WHO initiative is part of a broader global effort to combat non-communicable diseases and improve health outcomes worldwide. If you have specific questions about how this initiative is being implemented in a particular region or country, or if you need more detailed statistics or updates, please let me know, and I can perform a search to get you the most current information available.
1
0
1
Its here!
The WHO Reporting System for System for Lymph Node, Spleen, and Thymus Cytopathology is now available in print📘. This is the 3rd volume of the new series of reporting systems for cytopathology, which is a joint project with @IACytology.
0
0
1